ANA ISABEL
TORRES SUÁREZ
Catedrática de universidad
ANA MARÍA
FERNÁNDEZ CARBALLIDO
Profesora titular de universidad
Publicaciones en las que colabora con ANA MARÍA FERNÁNDEZ CARBALLIDO (25)
2023
-
Cannabidiol (CBD) use in breast cancer chemotherapy
Medicinal Usage of Cannabis and Cannabinoids (Elsevier), pp. 373-383
-
Capacitación de alumnos de pregrado en la generación de contenidos divulgativos de Farmacia y Tecnología Farmacéutica para su difusión en entornos virtuales
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
Sociedad Española de Farmacia Industrial y Galénica
2022
-
Active targeted nanoformulations via folate receptors: State of the art and future perspectives
Pharmaceutics, Vol. 14, Núm. 1
-
Aplicación de las TIC en asignaturas teórico-prácticas del grado en Farmacia: tecnología farmacéutica y biofarmacia y farmacocinética
Jornada «Aprendizaje Eficaz con TIC en la UCM» (Universidad Complutense de Madrid), pp. 43-53
-
Current status of nanomedicine for breast cancer treatment
Targeted Nanomedicine for Breast Cancer Therapy (Elsevier), pp. 65-110
-
Limitations and challenges in the stability of cysteamine eye drop compounded formulations
Pharmaceuticals, Vol. 15, Núm. 1
2021
-
Matrix tablets based on a novel poly (magnesium acrylate) hydrogel for the treatment of inflammatory bowel diseases
International Journal of Pharmaceutics, Vol. 608
2020
-
CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer
International Journal of Pharmaceutics, Vol. 574
-
Controlled release of highly hydrophilic drugs from novel poly(Magnesium acrylate) matrix tablets
Pharmaceutics, Vol. 12, Núm. 2
-
Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 246-258
-
PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In vitro and in Ovo assessment
Pharmaceutics, Vol. 12, Núm. 5
-
Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1150
2019
-
Adquisición de competencias transversales mediante debates asíncronos: Diseño e implementación en las enseñanzas de tecnología farmacéutica
Innovación Docente e Investigación en Ciencias de la Salud (Dykinson), pp. 309-320
-
Capecitabine safety profile, innovative and generic adjuvant formulation of nonmetastatic colorectal cancer
Farmacia Hospitalaria, Vol. 73, Núm. 5, pp. 158-162
-
Current status of nanomedicine in the chemotherapy of breast cancer
Cancer Chemotherapy and Pharmacology, Vol. 84, Núm. 4, pp. 689-706
-
Quality of life in non-metastasic colorectal cancer patients in Folfox or Xelox therapy
Farmacia Hospitalaria, Vol. 43, Núm. 2, pp. 56-60
2018
-
New trends in the therapeutic approach to metastatic colorectal cancer
International Journal of Medical Sciences, Vol. 15, Núm. 7, pp. 659-665
2017
-
Cáncer colorrectal: prevención y tratamiento
Anales de la Real Academia Nacional de Farmacia, Vol. 83, Núm. 2, pp. 188-199
2016
-
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
Expert Opinion on Investigational Drugs, Vol. 25, Núm. 11, pp. 1311-1323